Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients?

Nephrology Dialysis Transplantation

Volumn 27, Issue 1, 2012, Pages 396-401

  Papakrivopoulou, Eugenia ^a   Lillywhite, Samuel ^a   Davenport, Andrew ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

bioimpedance; echocardiography; extracellular fluid; NTproBNP; peritoneal dialysis

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER;

ADULT; AGED; ALBUMIN BLOOD LEVEL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTRACELLULAR FLUID; FEMALE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HUMAN; HYPERTENSION; HYPOTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; URINE VOLUME;

ADULT; BIOLOGICAL MARKERS; BODY WATER; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; INFLAMMATION; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PERITONEAL DIALYSIS; PROGNOSIS;

EID: 84856679540     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr338     Document Type: Review

References (25)

1. Foley RN, Parfrey PS. Cardiovascular disease and mortality in ESRD. J Nephrol 1998; 11: 239-245 (Pubitemid 28511522)
2. Enia G, Mallamaci F, Benedetto FA et al. Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant 2001; 16: 1459-1464 (Pubitemid 32640604)
3. Obineche EN, Pathan JY, Fisher S et al. Natriuretic peptide and adrenomedullin levels in chronic renal failure and effects of peritoneal dialysis. Kidney Int 2006; 69: 152-156 (Pubitemid 43117751)
4. Wang AY, Lam CW, Wang M et al. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients. Nephrol Dial Transplant 2009; 24: 1962-1969
5. Bavbek N, Akay H, Altay M et al. Serum BNP concentration and left ventricular mass in CAPD and automated peritoneal dialysis patients. Perit Dial Int 2007; 27: 663-668 (Pubitemid 351843485)
6. Wang AY, Lam CW, Yu CM et al. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients. J Am Soc Nephrol 2007; 18: 321-330 (Pubitemid 46053444)
7. Booth J, Pinney J, Davenport A. N-terminal proBNP-marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol 2010; 5: 1036-1040
8. Jacobs LH, van de Kerkhof JJ, Mingels AM et al. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study. Nephrol Dial Transplant 2010; 25: 243-248
9. Lee JA, Kim DH, Yoo SJ et al. Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2006; 26: 360-365
10. Granja CA, Tailor PT, Gorban-Brennan N et al. Brain natriuretic peptide and impedance cardiography to assess volume status in peritoneal dialysis patients. Adv Perit Dial 2007; 23: 155-160
11. Paniagua R, Ventura MD, Avila-Díaz M et al. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant 2010; 25: 551-557
12. Twardowski ZJ. PET-a simple approach for determining prescriptions for adequate dialysis therapy. In: Khanna R, Nolph KD, Oreopoulos DG, Prowantt B et al. (eds). Advances in Peritoneal Dialysis. Part 5. Adequacy of Peritoneal Dialysis, Vol. 6. Toronto: Peritoneal Dialysis Bulletin Inc; 1990:186-191
13. Davenport A, Willicombe M. Comparison of fluid status in patients treated by different modalities of peritoneal dialysis using multi-frequency bioimpedance. Int J Artif Organs 2009; 32: 779-786
14. Davenport A, Willicombe MK. Hydration status does not influence peritoneal equilibration test ultrafiltration volumes. Clin J Am Soc Nephrol 2009; 4: 1207-1212
15. Bergström J, Fürst P, Alvestrand A et al. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 1993; 44: 1048-1057 (Pubitemid 23316473)
16. Moran N, Buscombe J, Davenport A. Predicting cardiac events using adenosine triphosphate myocardial perfusion scintography in renal transplant candidates. J Nephrol Renal Transplant 2008; 1: 41-52
17. Zoccali C, Mallamaci F, Benedetto FA et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12: 1508-1515 (Pubitemid 32666334)
18. Konings CJ, Kooman JP, Schonck M et al. Assessment of fluid status in peritoneal dialysis patients. Perit Dial Int 2002; 22: 683-692 (Pubitemid 36131498)
19. Konings CJ, Kooman JP, Schonck M et al. Influence of fluid status on techniques used to assess body composition in peritoneal dialysis patients. Perit Dial Int 2003; 23: 184-190 (Pubitemid 36410862)
20. Davenport A, Willicombe MK. Does diabetes mellitus predispose to increased fluid overload in peritoneal dialysis patients? Nephron Clin Pract 2010; 114: c60-c66
21. Paniagua R, Amato D, Mujais S et al. Predictive value of brain na-triuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial. Clin J Am Soc Nephrol 2008; 3: 407-415
22. Palmer SC, Yandle TG, Nicholls MG et al. Regional clearance of amino-terminal pro-brain natriuretic peptide from human plasma. Eur J Heart Fail 2009; 11: 832-839
23. Woodrow G. Extracellular water expansion: part of the malnutrition-inflammation-atherosclerosis syndrome? Perit Dial Int 2006; 26: 566-570 (Pubitemid 44669432)
24. Bargman JM, Thorpe KE, Churchill DN et al. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12: 2158-2162 (Pubitemid 32880353)
25. Termorshuizen F, Korevaar JC, Dekker FW et al. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 2003; 41: 1293-1302 (Pubitemid 36637986)